3. Respiratory

• Asthma- adult treatment guidance
• Asthma- paediatric treatment guidance
• Asthma-COPD Overlap Syndrome (ACOS)
• Management of Chronic Obstructive Pulmonary Disease (COPD)
• The environmental impact of inhalers
• Inhaled Corticosteroid Dose Comparison in Asthma
• Guidance on croup
• Nebulisation guidance
• Oxygen guidance
• 3.1 Bronchodilators
• 3.1.5 Respiratory devices (peak flow meters, spacers etc.) and nebuliser diluents
• 3.2 Corticosteroids
• 3.3 Cromoglicate and related therapy, leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors
• 3.4 Antihistamines, hyposensitisation, and allergic emergencies
• 3.5 Respiratory stimulants and pulmonary surfactants
• 3.7 Mucolytics
• 3.9 Cough preparations
• 3.10 Systemic nasal decongestants
• 3.11 Antifibrotics